(Reuters) – Boston Scientific said on Thursday the U.S. Federal Trade Commission (FTC) has requested additional information from the medical device maker related to its $3.7 billion deal to buy Axonics.
In a regulatory filing, Boston Scientific said Axonics has also received a request for additional information from the FTC and both the companies expect to respond promptly.
Boston said it now expects the deal, announced in January, to be completed in the second half of 2024 following the FTC’s request, compared to its previous estimate of first half.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar and Shinjini Ganguli)
Comments